₹4,594 Cr
59.17
₹78 Cr
As on 13-Aug-2024 IST
₹33.15
•
3.97%
₹834.20
₹875.00
₹888.90
₹853.60
3,80,033
₹506.80 - 888.90
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
| 34.78 | 35.99 | 38.53 | 51.28 | -13.67 | 13.32 | -- |
|
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
BSE Small Cap
| 24.81 | -1.39 | 17.32 | 50.92 | 26.42 | 33.21 | 18.27 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
| 4.02 | -44.14 | 18.08 | 69.20 | 1.86 | -22.73 | 0.84 |
|
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Thyrocare Technologies Ltd stood at ₹ 644 Cr as on 30-Jun-24
The share price of Thyrocare Technologies Ltd is ₹867.35 (NSE) and ₹867.60 (BSE) as of 13-Aug-2024 IST. Thyrocare Technologies Ltd has given a return of -13.67% in the last 3 years.
Thyrocare Technologies Ltd has a market capitalisation of ₹ 4,594 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Thyrocare Technologies Ltd is 8.40 times as on 13-Aug-2024, a 9% discount to its peers’ median range of 9.24 times.
The P/E ratio of Thyrocare Technologies Ltd is 59.17 times as on 13-Aug-2024, a 2% discount to its peers’ median range of 60.36 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Thyrocare Technologies Ltd and enter the required number of quantities and click on buy to purchase the shares of Thyrocare Technologies Ltd.
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
The promoter of Thyrocare Technologies Ltd is Docon Technologies Private Limited. Docon Technologies Private Limited owns 71.11 per cent of the total equity. The chairman of the company is , and the managing director is Rahul Guha..
The promoters of Thyrocare Technologies Ltd have pledged 71.11% of the total equity as on Jun-24.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,547
|
|
|
8,537
|
|
|
2,244
|
|
|
956
|
| Thyrocare Technologies Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
15.33
|
|
Operating margin(%)
|
16.34
|
|
Net Margin(%)
|
12.59
|
|
Dividend yield(%)
|
2.07
|
Yes, TTM profit after tax of Thyrocare Technologies Ltd was ₹78 Cr.
₹4,594.17 Cr
₹593.90 Cr
₹77.64 Cr
₹176.64 Cr
₹21.60 Cr
71.11%
High
₹506.80 - 888.90
₹10.00
5,29,52,676
BSE: 539871, NSE: THYROCARE
Navi Mumbai, Maharashtra
www.thyrocare.com
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical... diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Read more
Stocks 
Thyrocare Technologies Ltd.
Widely used:
